D
Interpace Biosciences, Inc. IDXG
$0.9077 -$0.0823-8.31% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 13.25% 257.25% 274.46% 491.46% 129.99%
Total Depreciation and Amortization -10.95% -38.45% -53.28% -73.33% -70.41%
Total Amortization of Deferred Charges 85.71% -60.71% -- -100.00% -75.44%
Total Other Non-Cash Items -5.21% -45.39% -38.89% -57.07% -93.36%
Change in Net Operating Assets 34.54% -62.97% -247.45% -202.49% 40.33%
Cash from Operations 40.77% 128.60% 22.62% 93.93% 281.73%
Capital Expenditure -64.16% -95.84% -86.38% -69.66% -25.97%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- 100.00% -92.20%
Cash from Investing -4,384.21% -1,596.00% -906.90% 14.85% -100.32%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -34.15% -132.14% -124.00% -64.00% -310.00%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -43.75% -43.75% -43.75% 70.37% 70.37%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 93.04% 93.56% 93.56% -- --
Cash from Financing 13.75% -25.79% -15.40% -154.49% -526.25%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 50.42% 41.95% -53.16% -128.58% -203.24%